The renal and cardiac benefits of the ACE inhibitors and AT1 receptor blockers of Ang II in patients with arterial hypertension, cardiovascular illness, and diabetes mellitus seem to be partly [102] independent of their effects in reducing arterial pressure [27]. This evidence concerns the gene AGTR1 and Hypertension.